Galderma
Galderma is a global dermatology-focused company established in 1981, originally as a joint venture between Nestle and L'Oreal. It became a standalone entity in 2019 and is dedicated to providing innovative medical solutions for various dermatological conditions throughout the lifespan of individuals. With a workforce of approximately 6,600 employees and a presence in 80 countries, Galderma offers a diverse product portfolio that addresses issues such as acne, rosacea, psoriasis, and skin cancer. Key brands include Epiduo, Oracea, Differin, and Restylane, among others. The company emphasizes a science-based approach across multiple dermatology categories, including therapeutic solutions, dermatological skincare, and injectable aesthetics.
Alastin Skincare
Acquisition in 2021
Alastin Skincare, founded in 2015 and based in Carlsbad, California, specializes in innovative and clinically validated skincare products designed to correct, protect, and maintain healthy skin. The company produces topical skincare solutions that enhance both ablative and non-ablative rejuvenating procedures. Utilizing a proprietary blend of peptides and other scientifically-backed ingredients, Alastin's products support the skin's natural regenerative processes. Their offerings are specifically formulated for use by dermatologists and plastic surgeons, ensuring that patients receive effective treatments that promote long-term skin health. Alastin Skincare is dedicated to reawakening the skin’s youthful qualities through advanced technology and rigorous clinical testing.
Q-Med is a medical device company that specializes in the development, manufacturing, marketing, and sale of medical implants. The company is known for its patented technology, NASHA™, which enables the production of stabilized non-animal hyaluronic acid. Q-Med's product portfolio includes implants utilized in various medical fields, such as aesthetics, uro-gynecology, cell therapy, and encapsulation. By focusing on innovative solutions, Q-Med aims to address specific medical needs while enhancing patient outcomes.
CollaGenex Pharmaceuticals
Acquisition in 2008
CollaGenex Pharmaceuticals is a medical company based in Newtown, Pennsylvania, specializing in the development and marketing of innovative proprietary therapies for the dermatology market. The company's focus is on creating advanced medical treatments aimed at addressing various skin conditions, thereby contributing to advancements in dermatological healthcare.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.